RLAY
Relay TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RLAY vs peer average
46/100
RLAY vs. peer average (C vs. C)
Grade spread
A 1 · B 4 · C 4 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ELVN is the first available peer comparator.
Enliven is another similarly sized clinical oncology peer where valuation is driven by program readouts and regulatory path, making it a reasonable comparison for binary catalyst risk rather than indication overlap.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RLAY
Relay Therapeutics
ELVN
Enliven Therapeutics
Grade
C
B
Momentum
91
73
Value
41
41
Sentiment
32
58
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ELVN
RLAY / ELVN
Grade Position
In line
RLAY vs. peer average (C vs. C)
46/100
Momentum
91
RLAYValue
41
RLAYSentiment
32
ELVNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RLAY
ELVN is the first peer returned for this comparison set.